Janux Therapeutics Inc (JANX)
48.85
+0.89
(+1.86%)
USD |
NASDAQ |
Apr 18, 16:00
48.76
-0.09
(-0.18%)
After-Hours: 20:00
Janux Therapeutics Price: 48.85 for April 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 47.87 | 49.00 | 47.32 | 48.85 | 396251.0 |
Apr 17, 2024 | 50.00 | 51.40 | 47.28 | 47.96 | 614427.0 |
Apr 16, 2024 | 52.10 | 52.33 | 50.02 | 50.55 | 536776.0 |
Apr 15, 2024 | 51.05 | 54.59 | 50.43 | 51.86 | 1.041M |
Apr 12, 2024 | 49.94 | 54.76 | 49.53 | 52.65 | 1.527M |
Apr 11, 2024 | 47.06 | 56.27 | 47.00 | 50.00 | 2.686M |
Apr 10, 2024 | 39.00 | 49.00 | 38.08 | 44.62 | 3.343M |
Apr 09, 2024 | 38.60 | 40.54 | 38.43 | 40.03 | 703432.0 |
Apr 08, 2024 | 35.46 | 39.05 | 34.92 | 38.63 | 300488.0 |
Apr 05, 2024 | 35.16 | 35.68 | 34.63 | 35.12 | 278739.0 |
Apr 04, 2024 | 36.95 | 37.77 | 35.32 | 35.40 | 307357.0 |
Apr 03, 2024 | 36.33 | 36.45 | 35.11 | 36.34 | 312538.0 |
Apr 02, 2024 | 36.23 | 36.60 | 34.75 | 35.87 | 521904.0 |
Apr 01, 2024 | 37.62 | 38.10 | 35.33 | 37.69 | 286865.0 |
Mar 28, 2024 | 38.35 | 39.23 | 36.94 | 37.65 | 395979.0 |
Mar 27, 2024 | 39.29 | 39.88 | 37.50 | 37.92 | 397391.0 |
Mar 26, 2024 | 38.90 | 40.31 | 38.55 | 38.84 | 355146.0 |
Mar 25, 2024 | 39.80 | 41.72 | 38.18 | 38.53 | 293294.0 |
Mar 22, 2024 | 40.00 | 40.58 | 38.51 | 39.53 | 244144.0 |
Mar 21, 2024 | 40.15 | 40.98 | 38.58 | 39.85 | 595447.0 |
Mar 20, 2024 | 40.93 | 41.78 | 38.02 | 39.13 | 442821.0 |
Mar 19, 2024 | 37.28 | 40.35 | 37.23 | 38.63 | 1.028M |
Mar 18, 2024 | 39.81 | 40.30 | 37.46 | 38.81 | 208073.0 |
Mar 15, 2024 | 37.51 | 39.71 | 36.81 | 39.45 | 848640.0 |
Mar 14, 2024 | 40.00 | 40.00 | 36.44 | 37.77 | 542824.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.85
Minimum
Nov 09 2023
52.65
Maximum
Apr 12 2024
16.83
Average
14.08
Median
Price Benchmarks
Viking Therapeutics Inc | 64.73 |
Equillium Inc | 1.73 |
Minerva Neurosciences Inc | 2.50 |
Arvinas Inc | 34.29 |
Calidi Biotherapeutics Inc | 0.16 |
Price Related Metrics
PS Ratio | 265.95 |
Price to Book Value | 7.329 |
Earnings Yield | -2.72% |
Market Cap | 2.524B |